Abstract:Aim: To observe the effect of long-time intake of phecyclidine (PCP), the receptor antagonist of noncompetitive N-methyl-D-aspartic acid (NMDA), on the social behavior of mice, and establish animal models of schizophrenia as well as observe the interventional effects of different antipsychotics on mouse models. Methods: The experiment was conducted in the Animal Laboratory of Medical Department, Nagoya University of Japan between June and September 2003. 1 First experiment, the effects of PCP on social behavior of mice at different dose and administration time: 60 DDY male mice of 6 months old were randomly divided into 5 groups after 2-week feeding with 12 mice in each group and fed in two separate coops. Mice in high-dose long-term PCP group were treated with 10 mg/kg for 14 days. Mice in low-dose long-term PCP group were treated with 3 mg/kg for 14 days, and mice in long-term administration control group were treated with normal saline for 14 days. Mice in high-dose short-term PCP group were treated with 3 mg/kg for 14 days. Mice in long-term administration control group were treated with normal saline for 14 days. Mice in high-dose short-term PCP group were treated with 10 mg/kg for 7 days. Mice in short-term administration control group were treated with normal saline for 7 days. All mice were administrated by subcutaneous injection. The social behaviors of mice were tested respectively on the 36rd, 7th, 14th, 21st and 28th day after drug withdrawal. 2 Second experiment. The effects of antipsychotics PCP on the social behaviors of mice: another 60 mice were randomly divided into 5 groups with 12 rats in each group, which were fed in two separate coops. Mice in high-dose clozapine group were continuously injected with high-dose PCP for 14 days, and then were injected with clozapine 3 mg/kg per day for 7 days at 14 days after withdrawal. Mice in high-dose aloperidin group were continuously injected with high dose of PCP for 14 days and then were injected with aloperidin 3 mg/kg per day for 7 days at 14 days after withdrawal. Mice in low-dose aloperidin group were continuously injected with high-dose alperidin for 14 days, and then were injected with alperidin 1 mg/kg per day for 7 days. Mice in the normal saline group were continuously injected with normal saline for 14 days and then were injected with normal saline for 7 days at 14 days after withdrawal. Social behaviors were tested on withdrawal day and 7 days after withdrawal. Results: All of 120 mice were involved in the analysis of results, and no one withdrew from the study. 1 The first experiment showed that the social behavior of rats in the high-dose long-term PCP group were reduced respective on the 3rd, 7th, 14th, 21st and 28th day after withdrawal [(16.8±4.3), (13.4±3.5), (15.5±3.9), (28.2±5.0), (32.5±4.9) s,P < 0.01], which continued on the 28th day after withdrawal. 2 The second experiment showed that the social behavior deficit of mice induced by continuous administration of high-dose PCP was obviously ameliorated at 7 days after continuous treatment with clozapine [before administration: (13.8±1.6) s, the day of drug withdrawal: (143.1±36.1) s, 7 days after withdrawal: (64.8±10.3) s, P < 0.01,P < 0.05]. There was no changes in the social behavior deficit of mice induced by low-dose of clozapine and PCP at 7 days after that. The effect of clozapine on social behavior of mice induced by PCP was attenuated at one week after withdrawal. There was no ameliorating effect of aloperidin on the social behavior of mice induced by PCP. Conclusion: The social behavior of mice can be reduced by long-term administration of PCP (10 mg/kg), while the clozapine (10 mg/kg·day) has anti-effect on that mentioned above, which indicate that long-term administration of PCP, which can change the social behavior of mice, can be taken as the antipsychotics in the treatment of social behavior animal model of schizophrenia.

Effects of clozapine on the hypoglutamatergic schizophrenia model in mice

Effects of olanzapine on the hypoglutamatergic schizophrenia model in mice

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Comparison of risperidone and clozapine effects on MK-801-induced disruption of prepulse inhibition in mice

Effects of haloperidol on MK-801-induced hyperlocomotion and deficits of prepulse inhibition in mice.

Effects of acute treatment of dizocilpine maleate on locomotor activity, prepulse inhibition and object recognition memory in rats n

Interaction of clozapine with metformin in a schizophrenia rat model

Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action

Bimodal Effects of MK-801 on Locomotion and Stereotypy in C57BL/6 Mice

Behavioral effects of mogrosideⅤon the schizoid mouse model induced by dizocilpine maleate

Effect of GNTI, a Kappa Opioid Receptor Antagonist, on MK-801-induced Hyperlocomotion and Stereotypy in Mice

[Animal Models of Schizophrenia Using Different Laboratory Mouse Strains].

Social behavior in animal model of schizophrenia and the effects of antipsychotics

Bromocriptine and clozapine regulate dopamine 2 receptor gene expression in the mouse striatum

Metabolomic Analysis Reveals Metabolic Disturbance in the Cortex and Hippocampus of Subchronic Mk-801 Treated Rats

Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801

Contrasting Effects of Oxytocin on MK801-Induced Social and Non-Social Behavior Impairment and Hyperactivity in a Genetic Rat Model of Schizophrenia-Linked Features

Effects of Clozapine on Cortical Inhibition

Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia

Protective Effects of Shi-Zhen-An-Shen Decoction on the Cognitive Impairment in MK801-Induced Schizophrenia Model

Age-related Differential Sensitivity to MK-801-induced Locomotion and Stereotypy in C57BL/6 Mice.